Investment Philosophy


Our strategic focus is on the following selected pillars of oncology: Diagnostics (Genetic Sequencing, Metabolic Profiling, Early Detection), Therapeutics (Immunoncology, Precision Medicine, Targeted Therapy) and ‘Beyond the pill’ (Integrative Oncology, Digital Health, Patient Empowerment). These are considered to have the highest positive impact on survivability and quality of life, thus creating the greatest investment value.

Our portfolio includes investments in innovative oncology-related companies with strong upside potential and a pipeline which includes breakthrough technologies led by successful serial entrepreneurs.